Use of a cannabinoid CB1 receptor antagonist for preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy

Details for Australian Patent Application No. 2007255265 (hide)

Owner SANOFI-AVENTIS

Inventors Guagnini, Fabio; Avallone, Roberta; Croci, Tiziano

Agent A J Park

Pub. Number AU-A-2007255265

PCT Pub. Number WO2007/141413

Priority 0605074 07.06.06 FR

Filing date 1 June 2007

Wipo publication date 13 December 2007

International Classifications

A61K 31/454 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/141413 Priority application(s): WO2007/141413

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255266-Wind power machine provided with an articulated mast

2007255264-Method of measuring, on the fly, the height of an electrolysis anode